Health Economics in the Field of Prosthetics and Orthotics: A Global Perspective.
Disability
Health Economics
Health Technology Assessment
Manufacturer
Orthotics
Prosthetics
Reimbursement
Research and Development
Willingness to Pay
Journal
Canadian prosthetics & orthotics journal
ISSN: 2561-987X
Titre abrégé: Can Prosthet Orthot J
Pays: Canada
ID NLM: 101775715
Informations de publication
Date de publication:
2021
2021
Historique:
medline:
21
9
2021
pubmed:
21
9
2021
entrez:
24
8
2023
Statut:
epublish
Résumé
The rapid advancement of prosthetic and orthotic (P&O) technology raises the question how the industry can ensure that patients have access to the benefits and providers get paid properly and fairly by healthcare payers. This is a challenge that not only P&O but all areas of health technology face. In many areas of medicine and health products, such as drugs and medical devices, health-technology assessments (HTA) have become a standard procedure in the coverage and reimbursement process. In most countries, P&O is lagging behind that development, although some countries have already formalized HTA for prosthetic and orthotic products and may even use cost-effectiveness analyses to determine pricing and payment amounts. This article gives an overview on the coverage and reimbursement processes in the United States, Canada, Germany, France, Sweden, the United Kingdom, Poland, Japan, and China. This selection reflects the variety and diversity of coverage and reimbursement processes that the P&O industry faces globally. The paper continues with an overview on the necessary research and investment efforts that manufacturers will have to make in the future, and contemplates the likely consequences for the manufacturer community in the market place. Health economics may help support the transition from price-based to value-based coverage and reimbursement but will come at considerable costs to the industry.
Identifiants
pubmed: 37615010
doi: 10.33137/cpoj.v4i2.35298
pii: cpoj.v4i2.35298
pmc: PMC10443514
doi:
Types de publication
Journal Article
Langues
eng
Pagination
35298Informations de copyright
Copyright (c) 2021 Kannenberg A, Seidinger S.
Déclaration de conflit d'intérêts
Both authors are full-time employees of Otto Bock Healthcare.
Références
Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
Health Aff (Millwood). 2020 Jan;39(1):8-17
pubmed: 31804875
Prosthet Orthot Int. 2017 Jun;41(3):227-236
pubmed: 27025244
PLoS Med. 2017 Oct 2;14(10):e1002397
pubmed: 28968399
Health Policy. 2016 Apr;120(4):356-61
pubmed: 26994865
Eur J Health Econ. 2009 Feb;10(1):47-55
pubmed: 18379831
Biosci Trends. 2018;12(2):102-108
pubmed: 29760354
Value Health. 2019 Jan;22(1):13-20
pubmed: 30661627
Value Health. 2009 Jun;12(4):402-4
pubmed: 19138306
Acta Orthop. 2020 Aug;91(4):464-470
pubmed: 32316805
Med Care. 2001 Apr;39(4):315-26
pubmed: 11329519
J Rehabil Res Dev. 2014;51(8):1229-42
pubmed: 25625226
Prosthet Orthot Int. 2021 Feb;45(1):62-75
pubmed: 33834746
Bull World Health Organ. 2015 Feb 1;93(2):118-24
pubmed: 25883405
Value Health Reg Issues. 2018 May;15:138-148
pubmed: 29729645
Health Technol Assess. 2016 Jul;20(55):1-262
pubmed: 27477023
Health Econ. 2017 Feb;26 Suppl 1:13-29
pubmed: 28139087
Value Health Reg Issues. 2020 May;21:39-44
pubmed: 31634795
J Med Econ. 2020 Apr;23(4):317-322
pubmed: 31944134
Can Prosthet Orthot J. 2020 Mar 16;2(2):33489
pubmed: 37614768
PLoS One. 2015 May 28;10(5):e0124995
pubmed: 26020248
Bone Joint J. 2018 Apr 1;100-B(4):527-534
pubmed: 29629586
J Rehabil Res Dev. 2014;51(3):429-37
pubmed: 25019665
Pharmacoeconomics. 2008;26(9):733-44
pubmed: 18767894
Technol Innov. 2016 Sep;18(2-3):139-150
pubmed: 27917268
Int J Technol Assess Health Care. 2019;35(6):452-460
pubmed: 30894242
N Engl J Med. 2020 Aug 13;383(7):605-608
pubmed: 32786184
Eur J Health Econ. 2020 Apr;21(3):437-449
pubmed: 31897813
Eur J Health Econ. 2005 Dec;Suppl:58-65
pubmed: 16258749
J Neuroeng Rehabil. 2018 Sep 5;15(Suppl 1):62
pubmed: 30255802
J Pers Med. 2017 Sep 04;7(3):
pubmed: 28869571